TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
VNDA

Vanda Pharmaceuticals Inc

Healthcare · Biotechnology

5.10$ +2.2% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Vanda Pharmaceuticals Inc (VNDA): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/04/2026.

Next report 11/04/2026
Last report 08/05/2026
Earnings surprise by quarter (%)
Q3 23 · 106.0 % 23 Q4 23 · 55.6 % 23 Q1 24 · -240.0 % 24 Q2 24 · 61.9 % 24 Q3 24 · 43.8 % 24 Q4 24 · 27.3 % 24 Q1 25 · 16.7 % 25 Q2 25 · -27.8 % 25 Q3 25 · 15.6 % 25 Q4 25 · -81.1 % 25 Q1 26 · -18.8 % 26 Q2 26 · -103.9 % 26

EPS estimate beaten

Full history 51 of 80 quarters (64%)
Last 16 quarters 9 of 16 quarters (56%)

Earnings Call Transcripts

Search all transcripts →

  • 08/05/2026 Earnings Call Q2 2026 Open →
  • 05/06/2026 Earnings Call Q1 2026 Open →
  • 02/11/2026 Earnings Call Q4 2025 Open →
  • 10/29/2025 Earnings Call Q3 2025 Open →
  • 07/31/2025 Earnings Call Q2 2025 Open →
  • 05/07/2025 Earnings Call Q1 2025 Open →
  • 02/13/2025 Earnings Call Q4 2024 Open →
  • 11/06/2024 Earnings Call Q3 2024 Open →
  • 08/02/2024 Earnings Call Q2 2024 Open →
  • 05/08/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 08/05/2026 Vanda Pharmaceuticals Inc. (VNDA): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?